Consumer Electronics
Compare Stocks
2 / 10Stock Comparison
ZEPP vs SMPL
Revenue, margins, valuation, and 5-year total return — side by side.
Packaged Foods
ZEPP vs SMPL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Consumer Electronics | Packaged Foods |
| Market Cap | $242M | $1.24B |
| Revenue (TTM) | $1.68B | $1.45B |
| Net Income (TTM) | $-479M | $91M |
| Gross Margin | 37.2% | 34.0% |
| Operating Margin | -14.8% | 14.4% |
| Forward P/E | 213.9x | 7.5x |
| Total Debt | $1.33B | $304M |
| Cash & Equiv. | $808M | $98M |
ZEPP vs SMPL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Zepp Health Corpora… (ZEPP) | 100 | 39.8 | -60.2% |
| The Simply Good Foo… (SMPL) | 100 | 73.0 | -27.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ZEPP vs SMPL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ZEPP is the clearest fit if your priority is momentum.
- +490.9% vs SMPL's -64.8%
SMPL carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 0.38
- Rev growth 9.0%, EPS growth -26.1%, 3Y rev CAGR 7.5%
- 3.7% 10Y total return vs ZEPP's -66.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.0% revenue growth vs ZEPP's -46.6% | |
| Value | Lower P/E (7.5x vs 213.9x) | |
| Quality / Margins | 6.3% margin vs ZEPP's -28.5% | |
| Stability / Safety | Beta 0.38 vs ZEPP's 1.63, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +490.9% vs SMPL's -64.8% | |
| Efficiency (ROA) | 3.7% ROA vs ZEPP's -12.2%, ROIC 8.1% vs -9.8% |
ZEPP vs SMPL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ZEPP vs SMPL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — ZEPP and SMPL each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ZEPP and SMPL operate at a comparable scale, with $1.7B and $1.4B in trailing revenue. SMPL is the more profitable business, keeping 6.3% of every revenue dollar as net income compared to ZEPP's -28.5%. On growth, ZEPP holds the edge at +81.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.7B | $1.4B |
| EBITDAEarnings before interest/tax | -$227M | $231M |
| Net IncomeAfter-tax profit | -$479M | $91M |
| Free Cash FlowCash after capex | $0 | $174M |
| Gross MarginGross profit ÷ Revenue | +37.2% | +34.0% |
| Operating MarginEBIT ÷ Revenue | -14.8% | +14.4% |
| Net MarginNet income ÷ Revenue | -28.5% | +6.3% |
| FCF MarginFCF ÷ Revenue | -1.9% | +12.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +81.3% | -0.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +87.7% | -31.6% |
Valuation Metrics
SMPL leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $242M | $1.2B |
| Enterprise ValueMkt cap + debt − cash | $318M | $1.4B |
| Trailing P/EPrice ÷ TTM EPS | -2.98x | 12.20x |
| Forward P/EPrice ÷ next-FY EPS est. | 213.88x | 7.45x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.51x |
| EV / EBITDAEnterprise value multiple | — | 5.97x |
| Price / SalesMarket cap ÷ Revenue | 1.23x | 0.86x |
| Price / BookPrice ÷ Book value/share | 0.89x | 0.70x |
| Price / FCFMarket cap ÷ FCF | — | 7.86x |
Profitability & Efficiency
SMPL leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
SMPL delivers a 5.2% return on equity — every $100 of shareholder capital generates $5 in annual profit, vs $-28 for ZEPP. SMPL carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to ZEPP's 0.72x. On the Piotroski fundamental quality scale (0–9), SMPL scores 5/9 vs ZEPP's 2/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -28.4% | +5.2% |
| ROA (TTM)Return on assets | -12.2% | +3.7% |
| ROICReturn on invested capital | -9.8% | +8.1% |
| ROCEReturn on capital employed | -11.8% | +9.4% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 5 |
| Debt / EquityFinancial leverage | 0.72x | 0.17x |
| Net DebtTotal debt minus cash | $521M | $206M |
| Cash & Equiv.Liquid assets | $808M | $98M |
| Total DebtShort + long-term debt | $1.3B | $304M |
| Interest CoverageEBIT ÷ Interest expense | -7.83x | 6.77x |
Total Returns (Dividends Reinvested)
ZEPP leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ZEPP five years ago would be worth $3,932 today (with dividends reinvested), compared to $3,565 for SMPL. Over the past 12 months, ZEPP leads with a +490.9% total return vs SMPL's -64.8%. The 3-year compound annual growth rate (CAGR) favors ZEPP at 38.7% vs SMPL's -31.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -46.7% | -36.4% |
| 1-Year ReturnPast 12 months | +490.9% | -64.8% |
| 3-Year ReturnCumulative with dividends | +167.0% | -67.8% |
| 5-Year ReturnCumulative with dividends | -60.7% | -64.3% |
| 10-Year ReturnCumulative with dividends | -66.6% | +3.7% |
| CAGR (3Y)Annualised 3-year return | +38.7% | -31.5% |
Risk & Volatility
SMPL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SMPL is the less volatile stock with a 0.38 beta — it tends to amplify market swings less than ZEPP's 1.63 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SMPL currently trades 33.7% from its 52-week high vs ZEPP's 24.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.63x | 0.38x |
| 52-Week HighHighest price in past year | $61.85 | $36.92 |
| 52-Week LowLowest price in past year | $2.22 | $10.21 |
| % of 52W HighCurrent price vs 52-week peak | +24.2% | +33.7% |
| RSI (14)Momentum oscillator 0–100 | 61.7 | 42.9 |
| Avg Volume (50D)Average daily shares traded | 86K | 2.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Consensus price targets imply 62.1% upside for SMPL (target: $20) vs -19.7% for ZEPP (target: $12).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | $12.00 | $20.17 |
| # AnalystsCovering analysts | — | 24 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 2 | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | +4.1% |
SMPL leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). ZEPP leads in 1 (Total Returns). 1 tied.
ZEPP vs SMPL: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is ZEPP or SMPL a better buy right now?
For growth investors, The Simply Good Foods Company (SMPL) is the stronger pick with 9.
0% revenue growth year-over-year, versus -46. 6% for Zepp Health Corporation (ZEPP). The Simply Good Foods Company (SMPL) offers the better valuation at 12. 2x trailing P/E (7. 5x forward), making it the more compelling value choice. Analysts rate The Simply Good Foods Company (SMPL) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ZEPP or SMPL?
On forward P/E, The Simply Good Foods Company is actually cheaper at 7.
5x.
03Which is the better long-term investment — ZEPP or SMPL?
Over the past 5 years, Zepp Health Corporation (ZEPP) delivered a total return of -60.
7%, compared to -64. 3% for The Simply Good Foods Company (SMPL). Over 10 years, the gap is even starker: SMPL returned +3. 7% versus ZEPP's -66. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ZEPP or SMPL?
By beta (market sensitivity over 5 years), The Simply Good Foods Company (SMPL) is the lower-risk stock at 0.
38β versus Zepp Health Corporation's 1. 63β — meaning ZEPP is approximately 331% more volatile than SMPL relative to the S&P 500. On balance sheet safety, The Simply Good Foods Company (SMPL) carries a lower debt/equity ratio of 17% versus 72% for Zepp Health Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — ZEPP or SMPL?
By revenue growth (latest reported year), The Simply Good Foods Company (SMPL) is pulling ahead at 9.
0% versus -46. 6% for Zepp Health Corporation (ZEPP). On earnings-per-share growth, the picture is similar: The Simply Good Foods Company grew EPS -26. 1% year-over-year, compared to -1642. 9% for Zepp Health Corporation. Over a 3-year CAGR, SMPL leads at 7. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ZEPP or SMPL?
The Simply Good Foods Company (SMPL) is the more profitable company, earning 7.
1% net margin versus -41. 6% for Zepp Health Corporation — meaning it keeps 7. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SMPL leads at 15. 1% versus -25. 9% for ZEPP. At the gross margin level — before operating expenses — ZEPP leads at 38. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ZEPP or SMPL more undervalued right now?
On forward earnings alone, The Simply Good Foods Company (SMPL) trades at 7.
5x forward P/E versus 213. 9x for Zepp Health Corporation — 206. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SMPL: 62. 1% to $20. 17.
08Which pays a better dividend — ZEPP or SMPL?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is ZEPP or SMPL better for a retirement portfolio?
For long-horizon retirement investors, The Simply Good Foods Company (SMPL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
38)). Zepp Health Corporation (ZEPP) carries a higher beta of 1. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SMPL: +3. 7%, ZEPP: -66. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ZEPP and SMPL?
These companies operate in different sectors (ZEPP (Technology) and SMPL (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ZEPP is a small-cap quality compounder stock; SMPL is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.